• Mebicar

Expiration date: 05/2025

Active substance: Tetramethyltetraazabicyclooctandione

Structure and Composition:

1 tablet contains 0.3 g mebicar in blisters of 10 pcs., In a cardboard bundle two packaging

Pharmacokinetics:

Return with urine completely during the day.

Description of the pharmacological actions:

Potentiates the effects of hypnotics, and others. Deprimiruyuschie funds, regulates disturbed night's sleep without having a direct hypnotic action. It has no anticholinergic effect and muscle relaxant, does not violate the coordination of movements. Facilitates or relieves nicotine withdrawal symptoms.

Testimony:

Neuroses and neurosis-like states, false angina (not associated with CHD) reduction of craving for tobacco smoking, neurosis-like states in alcoholic patients in remission (fatigue, irritability, mood deterioration, obsessive craving for alcohol). To improve the tolerability of neuroleptics and tranquilizers.

Contraindications:

Hypersensitivity.

Side effect:

Rarely - diarrhea phenomenon allergic reactions.

Drug Interactions:

It can be combined with antipsychotics, hypnotics, antidepressants and psychostimulants.

Dosage and administration:

Inside, regardless of meals - at 0.3-0.6 g 3 times a day, for the treatment of smoking - by 0.6-0.9 g 3 times a day, to improve the tolerability of antipsychotics and tranquilizers - 0,9- 3.6 g / day, patients with alcoholism - 1.5-2.1 g / day. The maximum single dose - 3 grams daily - 10 g Duration of treatment from a few days to 2-3 months, with lung disorders situational healthy people enough single dose.

Mebicar